Yuwei Deng

Jul 30, 2024 | onlinelibrary.wiley.com | Jianli Ma |Yuwei Deng |Minghui Zhang |Qingyuan Zhang

CONFLICT OF INTEREST STATEMENT The authors reported no conflict of interest in this work. Supporting Information Filename Description imm13841-sup-0001-FigureS1.pdfPDF document, 575.2 KB Supplementary Figure 1. Kaplan–Meier estimates of progression-free survival by clinicopathological features. Stratified by (a) squamous and non-squamous, (b) PD-L1 status (TPS <1% vs. ≥1%), (c) brain metastases, (d) metastases sites (≤3 vs. >3) and (e) disease-free interval (DFI <6 months vs.

May 12, 2024 | onlinelibrary.wiley.com | Yuwei Deng |Qingyuan Zhang |Qiaoke Yan

1 INTRODUCTION Breast cancer is the most common cancer in women globally,1 accounting for approximately 31% of all female cancers,2 and the most prevalent histological subtype is invasive ductal carcinoma (IDC), accounting for 55% of all breast cancer cases.1 Besides, there are some other subtypes such as invasive lobular carcinoma (ILC), metaplastic breast carcinoma (MpBC), apocrine breast carcinoma (ABC), adenoid cystic carcinoma (ACC), and so on.3 As a rare histological subtype, MpBC...